PURPOSE We aimed to compare the effectiveness of intranasal desmopressin and doxazosin treatments in patients with nocturia and benign prostatic hyperplasia (BPH). MATERIAL AND METHODS Thirty one men with BPH and three or more episodes of nocturia were randomized to receive 2 mg doxazosin at night for two weeks increasing to 4 mg for a further two weeks versus 20 μg intranasal desmopressin at...

BACKGROUND Nocturia may be due to urological and non-urological diseases and some of the possible underlying non-urological diseases may be life-threatening. We investigated the efficacy and safety of lowest dose of oral desmopressin in treatment of nocturia in elderly men. METHODS 60 old men referring to urology clinic of Imam Reza hospital in Tehran, Iran from 2008-2009 for treatment of noc...

Abstract The present study investigated the association between severity of depressive mood and nocturia in young Asian adult men. Participants were 3127 male Facebook users aged 20–40 years who could read write traditional Chinese. completed online questionnaires on demographic characteristics, frequency waking to urinate during night (International Prostate Symptoms Score [IPSS]), symptoms (T...

Nocturia is a common disease in patients with type 2 diabetes mellitus that can reduce the quality of life. Sodium glucose co-transporter (SGLT2) inhibitors increase urine volume and are often discontinued when polyuria occurs, although tofogliflozin, which has short half-life blood, may improve nocturia by managing hyperglycemia hypertension, without aggravating nocturia. As excessive sodium i...

INTRODUCTION We reviewed our experience with the use of gabapentin to treat symptoms of overactive bladder (OAB) and nocturia in patients who have failed conventional anticholinergic therapy. METHODS Thirty-one patients referred to us with refractory (OAB) and/or nocturia were treated with oral gabapentin. All the patients had tried or remained on antimuscarinic drugs during treatment. Twenty...

PURPOSE Lower urinary tract symptoms are numerous, but the specific impact of each of these symptoms on the quality of life (QoL) has not been evaluated in community-dwelling men. An assessment of these symptoms and their effects on QoL was the focus of this study. METHODS We performed a cross-sectional study with 373 men aged >50 years from a community setting. Patients completed the Interna...

OBJECTIVES The objective of this study is to assess the impact of nocturia on sleep in patients with lower urinary tract symptoms (LUTS)/benign prostatic enlargement (BPE) (nocturia≥2). DESIGN Cross-sectional survey. SETTING 798 urologists and general practitioners randomly selected from the overall population of urologists and general practitioners of every French region. PARTICIPANTS A ...

Nocturia is a prevalent and highly bothersome lower urinary tract symptom (LUTS) affecting men and women of all ages. In waking to void there is disruption to an individual’s sleep that can lead to daytime tiredness and a loss of vitality. This may significantly impact upon physical, mental, and social wellbeing. It is recognised that nocturia has a multifactorial aetiopathogenesis that encompa...